title: Borderline-tuberculoid relapse in lepromatous leprosy.
abstract: We report details of 2 patients who had been treated for a long time by dapsone monotherapy and who had remained smear negative for over 10 years, but were found to have relapsed with borderline-tuberculoid (BT) leprosy.
authors.affiliation: Central JALMA Institute for Leprosy, Tajganj, AGRA, New Delhi.
authors.forename: B K
authors.initials: BK
authors.lastname: Girdhar
authors.forename: A
authors.initials: A
authors.lastname: Girdhar
authors.forename: S L
authors.initials: SL
authors.lastname: Chauhan
authors.forename: G N
authors.initials: GN
authors.lastname: Malaviya
authors.forename: S
authors.initials: S
authors.lastname: Husain
authors.forename: A
authors.initials: A
authors.lastname: Mukherjee
mesh_terms: D003622:Dapsone / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015439:Leprosy, Borderline / Q000473:pathology; D015440:Leprosy, Lepromatous / Q000188:drug therapy* / Q000473:pathology; D015441:Leprosy, Tuberculoid / Q000473:pathology; D008297:Male; D008875:Middle Aged; D012008:Recurrence
chemical_list: D003622:Dapsone